Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024
06 Março 2024 - 6:30PM
Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage
biopharmaceutical company focused on the discovery, development,
and commercialization of novel treatments for patients suffering
from serious hematologic diseases, announced today that company
management will participate in a fireside chat at the Leerink
Partners Global Biopharma Conference 2024 on Monday, March 11th at
10:40 am ET.
A live webcast of the fireside chat will be available through
the investor relations section of the Company's website at
ir.discmedicine.com and an archived replay will be available after
the event.
About Disc
Disc Medicine (NASDAQ:IRON) is a clinical-stage
biopharmaceutical company committed to discovering, developing, and
commercializing novel treatments for patients who suffer from
serious hematologic diseases. We are building a portfolio of
innovative, potentially first-in-class therapeutic candidates that
aim to address a wide spectrum of hematologic diseases by targeting
fundamental biological pathways of red blood cell biology,
specifically heme biosynthesis and iron homeostasis. For more
information, please visit www.discmedicine.com.
Media Contact
Peg RusconiVerge Scientific
Communicationsprusconi@vergescientific.com
Investor Relations Contact
Christina TartagliaStern Investor
Relationschristina.tartaglia@sternir.com
Disc Medicine (NASDAQ:IRON)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Disc Medicine (NASDAQ:IRON)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024